Literature DB >> 11301349

Highly proliferative fibroblasts forming fibrotic focus govern metastasis of invasive ductal carcinoma of the breast.

T Hasebe1, S Sasaki, S Imoto, A Ochiai.   

Abstract

We have already reported that invasive ductal carcinomas (IDCs) with fibrotic focus (FF) have more aggressive characteristics than those without FF. FF is composed of a mixture of fibroblasts and various amounts of collagen fibers, suggesting that highly proliferative fibroblasts forming FF increase the malignant potential of IDCs with FF. The purpose of this study was to examine whether there is a difference of proliferative activity of fibroblasts forming and not forming FF, which plays an important role in the tumor progression of IDCS: Two hundred three consecutive cases of IDC of the breast surgically treated at the National Cancer Center Hospital East formed the basis for this study. The proliferative activity of the fibroblasts forming the FF was immunohistochemically evaluated by using mouse MIB-1 monoclonal antibody against Ki-67 antigen. The MIB-1 labeling index (LI) is the percentage of fibroblasts forming FF that have positively stained nuclei, and 300 fibroblasts were counted in each FF. The significance of the proliferative activity of fibroblasts forming FF with regard to lymph node metastasis (LNM) or distant-organ metastasis (DOM) was compared with well-known prognostic parameters. Multivariate analysis demonstrated that high MIB-1 LI of fibroblasts forming FF significantly increased the relative risk of LNM and the hazard rate of DOM (P < .001 and P = .009). The present study indicated that the metastatic ability of IDCs with FF is highly dependent on the proliferative activity of the fibroblasts forming FF.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11301349     DOI: 10.1038/modpathol.3880310

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  14 in total

Review 1.  Stromal cells in tumor microenvironment and breast cancer.

Authors:  Yan Mao; Evan T Keller; David H Garfield; Kunwei Shen; Jianhua Wang
Journal:  Cancer Metastasis Rev       Date:  2013-06       Impact factor: 9.264

Review 2.  A visual-quantitative analysis of fibroblastic stromagenesis in breast cancer progression.

Authors:  Edna Cukierman
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-10       Impact factor: 2.673

Review 3.  The fibroblastic coconspirator in cancer progression.

Authors:  M Egeblad; L E Littlepage; Z Werb
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2005

Review 4.  Tumour-microenvironment interactions: role of tumour stroma and proteins produced by cancer-associated fibroblasts in chemotherapy response.

Authors:  Matthew David Hale; Jeremy David Hayden; Heike Irmgard Grabsch
Journal:  Cell Oncol (Dordr)       Date:  2013-03-14       Impact factor: 6.730

5.  Prognostic and predictive impact of central necrosis and fibrosis in early breast cancer: results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy.

Authors:  Eugenio Maiorano; Meredith M Regan; Giuseppe Viale; Mauro G Mastropasqua; Marco Colleoni; Monica Castiglione-Gertsch; Karen N Price; Richard D Gelber; Aron Goldhirsch; Alan S Coates
Journal:  Breast Cancer Res Treat       Date:  2009-03-12       Impact factor: 4.872

6.  Ovarian normal and tumor-associated fibroblasts retain in vivo stromal characteristics in a 3-D matrix-dependent manner.

Authors:  Roderick M Quiros; Matthildi Valianou; Youngjoo Kwon; Kimberly M Brown; Andrew K Godwin; Edna Cukierman
Journal:  Gynecol Oncol       Date:  2008-05-02       Impact factor: 5.482

7.  The prognostic significance of tumor-associated stroma in invasive breast carcinoma.

Authors:  Soomin Ahn; Junhun Cho; Jiyoun Sung; Jeong Eon Lee; Seok Jin Nam; Kyoung-Mee Kim; Eun Yoon Cho
Journal:  Tumour Biol       Date:  2012-05-13

8.  Prognostic significance of the intra-vessel tumor characteristics of invasive ductal carcinoma of the breast: a prospective study.

Authors:  Takahiro Hasebe; Satoshi Sasaki; Shigeru Imoto; Atsushi Ochiai
Journal:  Virchows Arch       Date:  2003-11-18       Impact factor: 4.064

9.  Angiotensin-(1-7) reduces fibrosis in orthotopic breast tumors.

Authors:  Katherine L Cook; Linda J Metheny-Barlow; E Ann Tallant; Patricia E Gallagher
Journal:  Cancer Res       Date:  2010-09-13       Impact factor: 13.312

Review 10.  Host microenvironment in breast cancer development: extracellular matrix-stromal cell contribution to neoplastic phenotype of epithelial cells in the breast.

Authors:  Malathy P V Shekhar; Robert Pauley; Gloria Heppner
Journal:  Breast Cancer Res       Date:  2003-02-20       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.